Association between dietary index for gut microbiota and metabolic syndrome risk: a cross-sectional analysis of NHANES 2007–2018
Open Access
- 30 April 2025
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Abstract
Metabolic syndrome (MetS) poses a significant global health challenge, closely associated with cardiovascular diseases, diabetes, and other conditions. With the global prevalence of MetS steadily rising, the potential role of gut microbiota in its development has garnered increasing attention. Against this backdrop, the present study aims to explore the association between the dietary index for gut microbiota (DI-GM) score and MetS. This cross-sectional study utilized data from the 2007–2018 U.S. National Health and Nutrition Examination Survey (NHANES), including 339,242 adults aged ≥ 18 years. The DI-GM score, constructed based on 14 food or nutrient components, served as the exposure variable. MetS was defined according to the Adult Treatment Panel III (ATP III) criteria, including abdominal obesity (waist circumference ≥ 102 cm in men and ≥ 88 cm in women), elevated triglycerides (≥ 150 mg/dL), reduced HDL cholesterol (< 40 mg/dL in men and < 50 mg/dL in women), elevated blood pressure (≥ 130/85 mmHg), and elevated fasting glucose (≥ 100 mg/dL). Multivariable logistic regression analyses were performed to adjust for demographic characteristics, lifestyle factors, and other potential confounders. Higher DI-GM scores were significantly associated with a reduced risk of MetS. After adjusting for all confounders, individuals in the highest quartile (Q4) of DI-GM scores had a 16% lower risk of MetS compared to those in the lowest quartile (Q1) (OR: 0.84; 95%CI: 0.70–1.01). Mediation analyses revealed that systemic immune-inflammation index (SII) and neutrophil-to-lymphocyte ratio (NLR) mediated 4.63% and 3.83% of the association between DI-GM and MetS, respectively. There is an inverse association between DI-GM scores and the risk of MetS, potentially mediated in part by inflammatory markers. These findings provide new evidence supporting dietary interventions aimed at improving gut microbiota to prevent MetS.Keywords
Funding Information
- High Level Chinese Medical Hospital Promotion Project (HLCMHPP2023079, HLCMHPP2023079, HLCMHPP2023079)
This publication has 60 references indexed in Scilit:
- Association of the newly proposed dietary index for gut microbiota and depression: the mediation effect of phenotypic age and body mass indexEuropean Archives of Psychiatry and Clinical Neuroscience, 2024
- Gut microbiota and healthy longevityScience China Life Sciences, 2024
- Randomized controlled trials reporting the effects of probiotics in individuals with overweight and obesity: A critical review of the interventions and body adiposity parametersClinical Nutrition, 2023
- Circadian Angiopoietin-Like-4 as a Novel Therapy in Cardiovascular DiseaseTrends in Molecular Medicine, 2021
- Trends in the Prevalence of Metabolic Syndrome in the United States, 2011-2016JAMA, 2020
- Mechanistic Understanding of the Symbiotic Relationship Between the Gut Microbiota and the HostCellular and Molecular Gastroenterology and Hepatology, 2020
- Dietary lipids, gut microbiota and lipid metabolismReviews in Endocrine and Metabolic Disorders, 2019
- Intestinal Crosstalk between Bile Acids and Microbiota and Its Impact on Host MetabolismCell Metabolism, 2016
- Metabolic SyndromeEndocrinology and Metabolism Clinics of North America, 2014
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001